Post-Traumatic Stress Disorder Treatment Market Report 2023 | R&D Consistency Drives Sector Growth

According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market demand is predicted to develop at a 5% CAGR from 2023 to 2033. The global market for post-traumatic stress disorder (PTSD) treatment is estimated to reach a value of US$ 27.37 billion by 2033. The market's expansion can be linked to the rising prevalence of PTSD worldwide.

Approximately 7-8% of the US population will experience PTSD at some point in their lives, according to the National Centre for PTSD, with higher rates among military veterans and individuals who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been identified as a potential cause of PTSD, with healthcare personnel, first responders, and those who have been directly affected by the virus being particularly vulnerable.

There is also a rising emphasis on using digital treatments and other non-pharmacological methods to treat PTSD. Virtual reality exposure therapy (VRET), for example, has demonstrated promising benefits in lowering PTSD symptoms by allowing clients to address their experience in a safe and controlled environment. Limbix and Psious, for example, are creating VRET platforms for the treatment of PTSD and other mental health issues.

Competitive Landscape

Key players in the post-traumatic stress disorder (PTSD) treatment market are: Jazz Pharmaceuticals, Aptinyx, Otsuka Pharmaceutical Development & Commercialization, Inc., Bionomics Limited, Merck KGaA, Pfizer Inc., Aurobindo Pharma Limited, GlaxoSmithKline plc, Viatris Inc., Jubilant Pharmova

Browse Detail Summary@ https://www.futuremarketinsights.com/reports/post-traumatic-stress-disorder-treatment-market

Key Segments Profiled in the Post-Traumatic Stress Disorder (PTSD) Treatment Industry Survey

By Drug Class:

  • Antidepressants
  • Anti-anxiety Drugs
  • Antipsychotics
  • Other Drug Classes

By Distribution Channel:

  • Retail Pharmacies
  • Online Pharmacies

Comments

Post a Comment

Popular posts from this blog

Portable Oxygen Concentrators Market | Innovative and Technological Advancement

Image
The global  portable oxygen concentrators market  is anticipated to witness lucrative growth opportunities over the forecast period from 2022 and 2032, with a phenomenal CAGR of 10.1%. The market is expected to enjoy a valuation of US$ 1.9 Billion by the end of the year 2022 and surpass a projection of US$ 5.0 Billion by the year 2032. According to the Future Market Insights historical analysis, the pulse flows portable oxygen concentrators were leading the market with a share of about 67.7% in the year 2021, within the global market. In the year 2021, the market value for portable oxygen concentrators was around 54.8% of the overall US$ 3.5 Billion of the global oxygen concentrators market. Portable oxygen concentrators supply oxygen to those patients who are suffering from respiratory diseases such as chronic obstructive pulmonary disease. In this process, nitrogen and oxygen are separated from the air in the environment with the help of the concentrator which then discards ...
Read more

Helicobacter Pylori Infections Treatment Market Research and Analysis 2023 to 2033

Image
The global helicobacter pylori infections treatment market is predicted to reach US$ 638.3 Million in 2023, with a compound annual growth rate (CAGR) of 7.04% anticipated from 2023 to 2033, reaching US$ 1,260 Million. The spread of such infections can be attributed to a number of factors, including a lack of adequate water supply, poor sanitation, a large population, and poor personal hygiene. One of the factors influencing the Helicobacter pylori diagnostics market's growth is increased awareness of H. pylori infections in the cohort. Antibiotic availability and affordability, as well as quicker processing times, will boost antibiotic use and the need for pre and post-surveillance tests. Furthermore, rising H. pylori infection rates, the need for early symptom diagnosis, and technological advances in diagnostic methods are expected to fuel overall growth over the forecast period. The key drivers of the industry are the increasing prevalence of communicable diseases and rising pub...
Read more

Pediatric Clinical Trials Market size is set to Grow at a Remarkable Pace by 2032

Image
During the forecast period 2022 to 2032, the global pediatric clinical trials market  is expected to grow at a value of 5.3%, according to Future Market Insights. In 2022, this market was predicted to have a global valuation of US$ 15.8 Billion, and is expected to reach a sum of US$ 26.47 Billion by 2032. The market is going to face increasing demand owing to the increase of pediatric chronic and genetic diseases all across the world. The growing need for novel vaccines and biopharmaceuticals to treat infectious diseases such as measles, polio, tuberculosis, rubella, influenza, mumps, whooping cough, malaria, chickenpox, and staphylococcus pharyngitis is expected to drive market growth. At the same time, diabetes is a big worry among today's children. The market is being driven by rising parental awareness of children clinical trials for severe infections and chronic diseases, as well as a large number of CROs doing pediatric research. In 2021, the onc...
Read more